A Multicenter, Single-arm, Prospective Phase I/II Trial of Mitoxantrone Hydrochloride Liposome Injection Combined With Chidamide in Relapsed or Refractory Peripheral T-cell Lymphoma
Latest Information Update: 15 Jan 2025
At a glance
- Drugs Mitoxantrone liposomal (Primary) ; Tucidinostat (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 17 Sep 2024 Status changed to recruiting, according to Results presented at the 49th European Society for Medical Oncology Congress
- 05 Sep 2022 New trial record